• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cardiovascular Implications of COVID-19 Infections.新型冠状病毒肺炎感染的心血管影响
Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):146-154. doi: 10.14797/mdcj-16-2-146.
2
The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients.心血管成像在住院 COVID-19 患者心肌损伤中的作用。
Eur Heart J Cardiovasc Imaging. 2020 Jul 1;21(7):709-714. doi: 10.1093/ehjci/jeaa136.
3
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China.新型冠状病毒肺炎患者疑似心肌损伤:来自中国武汉一线临床观察的证据。
Int J Cardiol. 2020 Jul 15;311:116-121. doi: 10.1016/j.ijcard.2020.03.087. Epub 2020 Apr 8.
4
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.《COVID-19 大流行对心血管的影响:全球视角》
Can J Cardiol. 2020 Jul;36(7):1068-1080. doi: 10.1016/j.cjca.2020.05.018. Epub 2020 May 16.
5
Effect of coronavirus infection on the human heart: A scoping review.冠状病毒感染对人类心脏的影响:范围综述。
Eur J Prev Cardiol. 2020 Jul;27(11):1136-1148. doi: 10.1177/2047487320925965. Epub 2020 May 18.
6
HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic.《关于大流行期间及之后远程医疗和心律失常监测的HRS/EHRA/APHRS/LAHRS/ACC/AHA全球实践更新》
Circ Arrhythm Electrophysiol. 2020 Jul;13(7):e009007. doi: 10.1161/CIRCEP.120.009007. Epub 2020 Jul 21.
7
Cardiovascular manifestations in severe and critical patients with COVID-19.COVID-19 重症及危重症患者的心血管表现。
Clin Cardiol. 2020 Jul;43(7):796-802. doi: 10.1002/clc.23384. Epub 2020 Jun 20.
8
Current data on the cardiovascular effects of COVID-19.关于新冠病毒病心血管影响的当前数据。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):46-48. doi: 10.1016/j.hjc.2020.04.001. Epub 2020 Apr 18.
9
Cardiovascular disease and COVID-19: les liaisons dangereuses.心血管疾病与 COVID-19:危险的关联。
Eur J Prev Cardiol. 2020 Jul;27(10):1017-1025. doi: 10.1177/2047487320924501. Epub 2020 May 11.
10
Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.编辑介绍:《危险关系。新冠疫情下的心脏》
Eur J Prev Cardiol. 2020 Jul;27(10):1011-1013. doi: 10.1177/2047487320936413.

引用本文的文献

1
Factors associated with mortality in patients with cardiovascular diseases affected by COVID-19: a cross-sectional study.2019冠状病毒病感染的心血管疾病患者的死亡相关因素:一项横断面研究
Rev Lat Am Enfermagem. 2025 May 19;33:e4551. doi: 10.1590/1518-8345.7609.4551. eCollection 2025.
2
Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study.八旬心衰患者在 COVID-19 封控期间的幸福感、身体活动和社会支持:一项混合方法研究。
Int J Environ Res Public Health. 2022 Nov 19;19(22):15316. doi: 10.3390/ijerph192215316.
3
Relative bradycardia in patients with COVID-19.新型冠状病毒肺炎患者的相对心动过缓
Int J Arrhythmia. 2022;23(1):22. doi: 10.1186/s42444-022-00073-z. Epub 2022 Sep 1.
4
A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients.新型冠状病毒肺炎患者心动过缓病因的多中心回顾性分析
Cureus. 2022 Jan 16;14(1):e21294. doi: 10.7759/cureus.21294. eCollection 2022 Jan.
5
The Way Ahead: Life After COVID-19.前路漫漫:新冠疫情后的生活
Methodist Debakey Cardiovasc J. 2021 Dec 15;17(5):83-88. doi: 10.14797/mdcvj.1056. eCollection 2021.
6
Noninvasive Imaging for Patients with COVID-19 and Acute Chest Pain.用于 COVID-19 与急性胸痛患者的非侵入性影像检查。
Methodist Debakey Cardiovasc J. 2021 Dec 15;17(5):5-15. doi: 10.14797/mdcvj.1040. eCollection 2021.
7
Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes.胸部计算机断层扫描显示的心血管表现与COVID-19不良临床结局相关。
Am Heart J Plus. 2021 Nov;11:100052. doi: 10.1016/j.ahjo.2021.100052. Epub 2021 Oct 13.
8
COVID-19 induced bradyarrhythmia and relative bradycardia: An overview.新冠病毒感染所致缓慢性心律失常及相对心动过缓:综述
J Arrhythm. 2021 Jun 14;37(4):888-892. doi: 10.1002/joa3.12578. eCollection 2021 Aug.
9
Teaching an old dog new tricks: The prognostic role of CACS in hospitalized COVID-19 patients.老狗学新招:冠状动脉钙化评分(CACS)在住院COVID-19患者中的预后作用
Atherosclerosis. 2021 Jul;328:106-107. doi: 10.1016/j.atherosclerosis.2021.05.015. Epub 2021 May 27.
10
A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases.免疫衰老与老年心血管疾病患者中高新冠病毒疾病相关死亡率之间的潜在关联。
Immun Ageing. 2021 Jun 1;18(1):25. doi: 10.1186/s12979-021-00234-z.

本文引用的文献

1
Multilead QT Screening Is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era.多导联QT筛查对于QT测量是必要的:对COVID-19时代患者管理的启示。
JACC Clin Electrophysiol. 2020 Jul;6(7):878-880. doi: 10.1016/j.jacep.2020.04.001. Epub 2020 Apr 7.
2
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.美国心力衰竭学会/美国心脏病学会/美国心脏协会联合声明回应关于在2019冠状病毒病中使用肾素-血管紧张素-醛固酮系统拮抗剂的担忧。
J Card Fail. 2020 May;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.
3
Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.2019 年冠状病毒病疫情期间武汉心脏移植受者的流行病学和临床特征:描述性调查研究报告。
J Heart Lung Transplant. 2020 May;39(5):412-417. doi: 10.1016/j.healun.2020.03.008. Epub 2020 Mar 25.
4
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会(ISTH)关于新冠病毒病(COVID-19)凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
5
Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic Endorsed by the American College of Cardiology.Society of Cardiovascular Computed Tomography 指导意见:在 COVID-19 大流行期间使用心脏计算机断层扫描技术 美国心脏病学会认可。
J Cardiovasc Comput Tomogr. 2020 Mar-Apr;14(2):101-104. doi: 10.1016/j.jcct.2020.03.002. Epub 2020 Mar 21.
6
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.住院 COVID-19 合并高血压患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的住院使用率与死亡率的关系。
Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17.
7
ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology.美国超声心动图学会关于在 2019 年新型冠状病毒爆发期间保护患者和超声心动图服务提供者的声明:得到美国心脏病学会的认可。
J Am Coll Cardiol. 2020 Jun 23;75(24):3078-3084. doi: 10.1016/j.jacc.2020.04.002. Epub 2020 Apr 6.
8
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
9
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
10
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.

新型冠状病毒肺炎感染的心血管影响

Cardiovascular Implications of COVID-19 Infections.

作者信息

Thakkar Akanksha N, Tea Isaac, Al-Mallah Mouaz H

机构信息

HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER, HOUSTON, TEXAS.

出版信息

Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):146-154. doi: 10.14797/mdcj-16-2-146.

DOI:10.14797/mdcj-16-2-146
PMID:32670475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7350814/
Abstract

Since early 2020, the world has been facing a pandemic caused by the novel coronavirus SARS-CoV-2. Although this positive single-stranded RNA virus primarily causes pulmonary infection and failure, it has been associated with multiple cardiovascular diseases including troponin elevation, myocarditis, and cardiac arrhythmias. Cardiac patients are susceptible to developing more severe infection from SARS-COV-2, making management complicated. In this review we discuss the cardiac manifestations of COVID-19 infections as well as considerations for the management of primary cardiac pathologies during this pandemic.

摘要

自2020年初以来,世界一直面临由新型冠状病毒SARS-CoV-2引发的大流行。尽管这种正链单链RNA病毒主要导致肺部感染和功能衰竭,但它还与多种心血管疾病有关,包括肌钙蛋白升高、心肌炎和心律失常。心脏病患者更容易因感染SARS-CoV-2而病情加重,这使得治疗变得复杂。在这篇综述中,我们讨论了COVID-19感染的心脏表现以及在此次大流行期间对原发性心脏疾病的治疗考量。